A personalized 3-month resistance exercise program improved walking distance and HRQOL in adults with persistent COVID-19 symptoms.

Transgender youth care could become harder to access with Trump administration officials planning to penalize hospitals and doctors who offer it.

FDA accepts BLA for INO-3107, a DNA immunotherapy for HPV-6 and HPV-11-associated recurrent respiratory papillomatosis.

Bacterial meningitis and sepsis in newborns significantly increased hospital stays, ICU utilization, and 1-year health care costs in the United States.

Among hypoxemic, non-HIV immunocompromised adults with PJP, greater cumulative CS exposure is associated with increased 90-day mortality.

Cancer is a leading cause of death for people living with HIV; at AANP 2025, experts discuss how to screen for and prevent cancer.

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

Adults with multiple high-risk conditions face higher COVID-19-related hospitalization risks than those with immunocompromising conditions alone.

President Donald Trump signed an executive order that could make it easier for scientists to study cannabis for medical use.